Skip to main content

Facilitating Collaborations to Develop Combination Investigational Therapies

Completed

Advances in biomedical research have increased our understanding of the complex nature of disease and the interaction of multiple molecular pathways involved in cancer. The National Cancer Policy Forum convened a public workshop in 2011 to address promises and challenges in the development of combination investigational cancer therapies. The workshop’s purpose was to identify barriers that hinder development of combination investigational cancer therapies and offer potential solutions for greater collaboration.

Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.